Sichuan Kelun Pharmaceutical Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
7/10
|
19.71 | 69.4 | -71.6% | 28 | -29.6% |
| P/S |
|
2.19 | 6.51 | -66.34% |
|
|
| P/BV |
|
2.58 | 3.96 | -34.79% |
|
|
| P/FCF |
|
0 | 0 | 0% |
|
|
| Ev/Ebitda |
|
13.5 | 11.85 | 13.94% |
|
|
| Ev/S |
|
2.25 | 5.98 | -62.42% |
|
|
| Ev/FCF |
|
0 | 0 | 0% |
|
|
| E/P |
|
0.0523 | 0.0396 | 32.09% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
4/10
|
14.83 | 16.34 | -9.24% | 17.43 | -14.93% |
| ROE |
|
14.39 | 11.95 | 20.46% |
|
|
| ROA |
|
5.3 | 5.4 | -1.88% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
11.13 | 16.23 | -31.43% |
|
|
| ROCE |
|
0 | 0 | 0% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
6/10
|
2.39 | 14.63 | -83.69% | 2.66 | -10.4% |
| Nеt Debt/Ebitda |
|
0 | 0 | 0% |
|
|
| Debt/Ratio |
|
0 | 0 | 0% |
|
|
| Debt/Equity |
|
0 | 0 | 0% |
|
|
| Debt/Net Income |
|
4.35 | 3.6 | 20.95% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
5.33/10
|
2.13 | 1.83 | 16.2% | 1.72 | +23.97% |
| Number of years of dividend growth |
|
2 | 1.44 | 39.13% | ||
| DSI |
|
0.9286 | 0.9113 | 1.89% |
|
|
| Average dividend growth |
|
20.62 | 10.4 | 98.35% |
|
|
| Average percentage for 5 years |
|
1.72 | 1.14 | 50.44% |
|
|
| Average percentage for payments |
|
67.84 | 44.8 | 51.42% |
|
|
| Difference from average difference in sector |
|
0.297 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
4/10
|
21.65 | 61.43 | -64.76% | ||
| Growth impulse Ebitda in 5 years |
|
26.7 | 158.62 | -83.17% | ||
| Growth impulse Net Income in 5 years |
|
161.89 | 66.93 | 141.88% | ||
| Growth impulse FCF in 5 years |
|
302.83 | 248.41 | 21.91% | ||
| Growth impulse EPS in 5 years |
|
101.19 | 73.29 | 38.07% |
IP Score
6.41/10
